These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fatal fungemia resulting from an infected transjugular intrahepatic portosystemic shunt stent. Schiano TD; Atillasoy E; Fiel MI; Wolf DC; Jaffe D; Cooper JM; Jonas ME; Bodenheimer HC; Min AD Am J Gastroenterol; 1997 Apr; 92(4):709-10. PubMed ID: 9128335 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy Jiang TT; Luo XP; Sun JM; Gao J World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701 [TBL] [Abstract][Full Text] [Related]
5. Control of a Candida glabrata prosthetic endovascular infection with posaconazole. Anstead GM; Martinez M; Graybill JR Med Mycol; 2006 May; 44(3):273-7. PubMed ID: 16702108 [TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt (TIPS). van der Heijde RM; Laméris JS; van den Berg B; Wagenvoort CA; Hilvering C; van Buuren HR Eur Respir J; 1996 Jul; 9(7):1562-4. PubMed ID: 8836674 [TBL] [Abstract][Full Text] [Related]
8. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208 [TBL] [Abstract][Full Text] [Related]
9. Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis. Klinger C; Riecken B; Schmidt A; De Gottardi A; Meier B; Bosch J; Caca K Z Gastroenterol; 2018 Mar; 56(3):221-237. PubMed ID: 29113006 [TBL] [Abstract][Full Text] [Related]
10. Disappearance of "pseudocholangiocarcinoma sign" in a patient with portal hypertension due to complete thrombosis of left portal vein and main portal vein web after web dilatation and transjugular intrahepatic portosystemic shunt. Bayraktar Y; Oztürk MA; Egesel T; Cekirge S; Balkanci F J Clin Gastroenterol; 2000 Dec; 31(4):328-32. PubMed ID: 11129276 [TBL] [Abstract][Full Text] [Related]
11. Early TIPS failure in association with left mesenterico-gonadal spontaneous portosystemic venous shunt; a case report. Raissi D; Roney EA; Issa MM; Sanampudi S; Winkler MA Clin Imaging; 2019; 53():200-203. PubMed ID: 30419415 [TBL] [Abstract][Full Text] [Related]
12. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement. Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721 [TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179 [TBL] [Abstract][Full Text] [Related]
14. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. Luo SH; Chu JG; Huang H; Zhao GR; Yao KC World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997 [TBL] [Abstract][Full Text] [Related]
15. A fistula from the portal vein to the bile duct: an unusual complication of transjugular intrahepatic portosystemic shunt. Willner IR; El-Sakr R; Werkman RF; Taylor WZ; Riely CA Am J Gastroenterol; 1998 Oct; 93(10):1952-5. PubMed ID: 9772063 [TBL] [Abstract][Full Text] [Related]
16. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651 [TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein. Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421 [TBL] [Abstract][Full Text] [Related]
18. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Salem R; Vouche M; Baker T; Herrero JI; Caicedo JC; Fryer J; Hickey R; Habib A; Abecassis M; Koller F; Vogelzang R; Desai K; Thornburg B; Hohlastos E; Resnick S; Lewandowski RJ; Sato K; Ryu RK; Ganger D; Kulik L Transplantation; 2015 Nov; 99(11):2347-55. PubMed ID: 25905983 [TBL] [Abstract][Full Text] [Related]
19. Hemorrhage risk with transjugular intrahepatic portosystemic shunt (TIPS) insertion at the main portal vein bifurcation with stent grafts. Griffin AS; Preece SR; Ronald J; Smith TP; Suhocki PV; Kim CY Diagn Interv Imaging; 2017 Dec; 98(12):837-842. PubMed ID: 28843589 [TBL] [Abstract][Full Text] [Related]
20. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation]. Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]